Loading company…
Xenome develops immunotherapy treatments for cancer and autoimmune disorders.
Xenome is a biotechnology company based in Brisbane, Australia, focused on therapies for cancer and autoimmune disorders. In December 2011, it raised AUD 8 mn in venture funding from existing investors Queensland BioCapital Fund and GBS Venture Partners. The supplied information also describes a domain name business under the Xenome name, but does not establish a connection to the biotechnology company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in